ATE350061T1 - Zusammensetzung zur behandlung von virusinfektionen, die einen calcium-kanal-blocker und ein chinolin enthält - Google Patents
Zusammensetzung zur behandlung von virusinfektionen, die einen calcium-kanal-blocker und ein chinolin enthältInfo
- Publication number
- ATE350061T1 ATE350061T1 AT00955850T AT00955850T ATE350061T1 AT E350061 T1 ATE350061 T1 AT E350061T1 AT 00955850 T AT00955850 T AT 00955850T AT 00955850 T AT00955850 T AT 00955850T AT E350061 T1 ATE350061 T1 AT E350061T1
- Authority
- AT
- Austria
- Prior art keywords
- quinoline
- treatment
- composition
- calcium channel
- channel blocker
- Prior art date
Links
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 title 2
- 229940127291 Calcium channel antagonist Drugs 0.000 title 1
- 241000700605 Viruses Species 0.000 title 1
- 239000000480 calcium channel blocker Substances 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15026199P | 1999-08-23 | 1999-08-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE350061T1 true ATE350061T1 (de) | 2007-01-15 |
Family
ID=22533745
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00955850T ATE350061T1 (de) | 1999-08-23 | 2000-08-23 | Zusammensetzung zur behandlung von virusinfektionen, die einen calcium-kanal-blocker und ein chinolin enthält |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1210116B1 (de) |
| CN (2) | CN1994466A (de) |
| AP (1) | AP1691A (de) |
| AT (1) | ATE350061T1 (de) |
| AU (1) | AU775903B2 (de) |
| DE (1) | DE60032777T2 (de) |
| WO (1) | WO2001013907A2 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7479498B2 (en) | 1999-08-23 | 2009-01-20 | Phoenix Biosciences, Inc. | Treatments for viral infections |
| CN1319531C (zh) * | 2005-06-08 | 2007-06-06 | 复旦大学 | 喹啉类生物碱在制备抗乙肝病毒药物中的用途 |
| US8889743B2 (en) * | 2007-06-20 | 2014-11-18 | Board Of Regents, University Of Texas System | Inhibition of filovirus entry into cells and uses thereof |
| SG11201405018VA (en) * | 2012-03-30 | 2014-09-26 | Univ Malaya | A composition having antiviral activity against flavivirus |
| WO2018002153A1 (en) * | 2016-06-28 | 2018-01-04 | Assistance Publique - Hopitaux De Paris | Hycanthone derivatives and primaquine derivatives for use in the prevention and/or the treatment of disorders associated to gammaherpesvirus |
| CN109820852B (zh) * | 2019-03-11 | 2021-02-19 | 中国农业科学院兰州兽医研究所 | 一种尼莫地平在制备预防口蹄疫病毒感染的药物中的应用 |
| FR3109723A1 (fr) * | 2020-05-04 | 2021-11-05 | Dyna + | Composition de renforcement et/ou de régulation de la réponse immunitaire |
| AU2023427324A1 (en) * | 2023-01-31 | 2025-09-11 | Griffith University | Methods of treating viral infection |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4897403A (en) * | 1986-11-18 | 1990-01-30 | The United States Of America As Represented By The Secretary Of The Army | Antimalarial compositions and methods |
| US5278173A (en) * | 1988-06-30 | 1994-01-11 | Davis Michael H | Method of inhibiting the activity of human immunodeficiency virus (HIV) in vivo |
| US5430039A (en) * | 1990-09-28 | 1995-07-04 | Cephalon, Inc. | Treatment of neurological disorders |
-
2000
- 2000-08-23 AU AU67988/00A patent/AU775903B2/en not_active Ceased
- 2000-08-23 EP EP00955850A patent/EP1210116B1/de not_active Expired - Lifetime
- 2000-08-23 DE DE60032777T patent/DE60032777T2/de not_active Expired - Fee Related
- 2000-08-23 AP APAP/P/2002/002432A patent/AP1691A/en active
- 2000-08-23 AT AT00955850T patent/ATE350061T1/de not_active IP Right Cessation
- 2000-08-23 CN CNA2006101604837A patent/CN1994466A/zh active Pending
- 2000-08-23 CN CNB008143579A patent/CN1297317C/zh not_active Expired - Fee Related
- 2000-08-23 WO PCT/US2000/023123 patent/WO2001013907A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CN1994466A (zh) | 2007-07-11 |
| EP1210116A2 (de) | 2002-06-05 |
| DE60032777D1 (de) | 2007-02-15 |
| AP1691A (en) | 2006-12-11 |
| AU775903B2 (en) | 2004-08-19 |
| DE60032777T2 (de) | 2007-11-08 |
| EP1210116B1 (de) | 2007-01-03 |
| CN1297317C (zh) | 2007-01-31 |
| CN1399558A (zh) | 2003-02-26 |
| WO2001013907A3 (en) | 2001-08-30 |
| AP2002002432A0 (en) | 2002-03-31 |
| AU6798800A (en) | 2001-03-19 |
| WO2001013907A2 (en) | 2001-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69943287D1 (de) | Antibiotische zusammensetzung, die moxifloxacin enthält, zur behandlung von augen | |
| ATE494884T1 (de) | Oxidative zusammensetzung zur behandlung von keratinfasern, die spezielle aminosilikone enthält | |
| DE60023043D1 (de) | (S,S)-Reboxetin zur Behandlung von Inkontinenz | |
| DE69940131D1 (de) | Mittel zur Behandlung von Erkrankungen der Speiseröhre | |
| DE10082139T1 (de) | Zusammensetzung zur Behandlung von Reibungspaaren | |
| DE50206657D1 (de) | Pharmazeutische zusammensetzung zur behandlung von multiple sklerose | |
| DE60019556D1 (de) | 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit | |
| DE69528109D1 (de) | Thieno -1,5- benzodiazepin zur Behandlung gastrointestinaler Beschwerden | |
| DE60019555D1 (de) | 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit | |
| DE60113496D1 (de) | Verwendung von Glycyrrhizin zur Behandlung von Mastitis. | |
| ATE318138T1 (de) | Pharmazeutisches mittel zur behandlung von diabetes | |
| ATE358117T1 (de) | Adamantanderivate zur behandlung von entzündlichen, immunologischen und kardiovaskulären erkrankungen | |
| DE60137631D1 (de) | Ireovirus antikörpern zur behandlung von ras-vermittelten, proliferativen erkrankungen | |
| DE60030554T8 (de) | Verwendungen von et743 zur behandlung von krebs | |
| DE69925865D1 (de) | 4-(aminomethyl)-piperidinbenzamide zur behandlung von gastrointestinalen störungen | |
| DE60132851D1 (de) | Arzneimittel zur Vorbeugung, Erleichterung oder Behandlung von Hypertension | |
| DE60112581D1 (de) | Zusammensetzungen zur behandlung baktrieller infektionen, welche ein oxazolidinonderivat, sulbactam und ampicillin enthalten | |
| DE50006142D1 (de) | Verfahren zur thermischen Behandlung von mehlförmigen Rohmaterialien | |
| ATE350061T1 (de) | Zusammensetzung zur behandlung von virusinfektionen, die einen calcium-kanal-blocker und ein chinolin enthält | |
| DE60016047D1 (de) | Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten | |
| ATE528004T1 (de) | Chinolon-antibiotika zur behandlung von periodontaler infektionen | |
| DE69913380D1 (de) | Zusammensetzung zur behandlung von periodontalen erkrankungen | |
| DE60006412D1 (de) | Oxazinochinolone zur behandlung von viralen infektionen | |
| DE60021252D1 (de) | Antikonvulsiva zur behandlung von autismus | |
| DE60001255D1 (de) | Zusammensetzung zur Behandlung von Polyesterfaser |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |